Início
Mercados
Gráficos e ideias
Algo
Notícias
Store
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
PCRX
#2109
Pacira BioSciences, Inc. Common Stock
21.910
0
-5.88%
Setor:
Base:
Moeda do lucro:
Faixa diária
Faixa anual
Mudança diária
-5.88%
Mudança mensal
+10.54%
Mudança em 6 meses
+0.37%
Mudança anual
+0.37%
Fechamento anterior
23.280
0
Open
21.910
0
Bid
Ask
Low
21.910
0
High
21.910
0
Volume
171
Mercados
Ações
Cuidados de saúde
PCRX
Open full chart
Financials
Overview
Relatórios
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
43.86 M
44.85 M
45.95 M
46.5 M
46.28 M
40.49 M
—
Valuation ratios
Enterprise value
2.52 B
2.11 B
1.68 B
1.33 B
595.07 M
889.33 M
3.49 B
Price to earnings ratio
17.97
65.4
114.29
35.96
-8.76
161.75
194.53
Price to sales ratio
6.08
5.07
2.71
2.46
119.65
—
—
Price to cash flow ratio
33.93
21.84
12.45
10.76
4.6
7.67
30.88
Price to book ratio
4.22
3.76
2.33
1.91
1.12
1.68
2.79
Enterprise value to EBITDA ratio
8.64
6.03
4.07
2.8
-1.67
—
—
Profitability ratios
Return on assets %
0.11
0.02
0.01
0.03
-0.06
0.01
-0.01
Return on equity %
0.23
0.06
0.02
0.05
-0.13
0.01
-0.02
Return on invested capital %
-155.42
22.44
13.41
19.05
-11.09
3.31
0.87
Gross margin %
72.69
74.1
70.11
72.64
-2 240.4
79.39
317.56
Operating margin %
10.79
16.61
9
12.99
-1 007.57
2.64
10.6
EBITDA margin %
68.05
64.67
61.97
70.6
-4 903.28
13.36
23.17
Net margin %
33.87
7.75
2.39
6.22
-1 367.21
0.97
-6.26
Liquidity ratios
Quick ratio
2.32
1.47
2.72
4.17
2
3.28
10.96
Current ratio
2.57
1.66
3.37
5.24
2.4
4.54
14.6
Inventory turnover
—
—
—
—
—
0.01
—
Asset turnover
0.41
0.32
0.36
0.41
0
0.52
0.5
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.25
0.33
0.39
0.33
0.25
0.29
1.07
Long term debt to total equity ratio
0.51
0.92
0.85
0.59
0.49
0.54
2.03
Per share metrics
Operating cash flow per share
1.76
2.76
3.12
2.98
4.1
3.37
3.32
EBIT per share
6.24
7.05
6.91
7.71
-9.42
0.13
-1.24
EBITDA per share
6.69
7.68
8.88
9.17
-7.72
2.15
0.75
Total debt per share
—
—
—
—
—
—
—
Cash per share
11.94
14.39
6.2
5.36
10.48
5.29
31.01
Net current asset value per share
14.92
18.98
10.71
9.81
16.11
12.17
57.06
Tangible book value per share
9.7
-0.85
1.53
4.3
7.62
6.77
28.08
Working capital per share
9.12
7.56
7.53
7.94
9.41
9.49
38.45
Book value per share
14.19
16.01
16.65
16.74
16.83
15.39
64.98
Notícias
Pacira BioSciences, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:PCRX) 2026-02-27
Pacira BioSciences Q4 Earnings and Revenues Miss Estimates, Stock Down
Resultados de Pacira en la mira ante amenaza de genéricos a EXPAREL
Resultados de Pacira en la mira ante amenaza genérica a EXPAREL
Pacira BioSciences: Mispriced On Generic Risks That Are Years Away (NASDAQ:PCRX)
Vicepresidenta de Pacira BioSciences vende acciones por 83.000 dólares
Vicepresidenta de Pacira BioSciences vende acciones por $83,000
Pacira BioSciences SVP Lauren Riker sells $83k in stock
Directivo de Pacira BioSciences vende acciones por 269.000 dólares
Directivo de Pacira BioSciences vende acciones por $269 mil
Pacira BioSciences officer Williams sells $269k in shares
5 Drug/Biotech Stocks Likely to Outperform Q4 Earnings Estimates